Ariad Pharmaceuticals, Inc. to Host Analyst & Investor Day in New York City

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Analyst & Investor Day for research analysts and institutional investors will take place on Friday, October 19 at 8:00 a.m. (ET) in New York City. Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD, will host the event, which will include other key members of ARIAD executive leadership. The meeting will focus on ARIAD’s commercial plans for ponatinib and continued progress in its research and development programs. An expert physician specializing in the treatment of patients with lung cancer will be a featured speaker and discussant at the meeting.

Back to news